started · updated
Hospital de Base to test new antibiotic against resistant bacteria
Hospital de Base in the Distrito Federal, managed by the Instituto de Gestão Estratégica de Saúde do Distrito Federal (IgesDF), will participate in a study testing a new class of antibiotics. The research targets infections caused by Acinetobacter, a bacterium known for its resistance to all currently tested treatments.
The initiative coincides with World Antimicrobial Awareness Week, held from November 18 to 24. The study will primarily take place in the Trauma Intensive Care Unit and the Hematology Clinic, areas serving patients at higher risk of infection.
In addition to this study, the hospital maintains several partnerships to combat antimicrobial resistance. These include collaborations with Hospital Israelita Albert Einstein to evaluate hospital cleaning products and Hospital Moinhos de Vento through the 'Saúde em Nossas Mãos' project to improve infection management in coronary intensive care units. The hospital also participates in a national monitoring project in partnership with Anvisa and the US CDC.
Entities
Acinetobacter · Anvisa · CDC · Hospital de Base · Instituto de Gestão Estratégica de Saúde do Distrito Federal